Your browser doesn't support javascript.
loading
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.
Derikx, Lauranne A A P; Plevris, Nikolas; Su, Shanna; Gros, Beatriz; Lyons, Mathew; Siakavellas, Spyros I; Constantine-Cooke, Nathan; Jenkinson, Philip; O'Hare, Claire; Noble, Colin; Arnott, Ian D; Jones, Gareth-Rhys; Lees, Charlie W.
Afiliação
  • Derikx LAAP; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, th
  • Plevris N; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Su S; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Gros B; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK; Department of Gastroenterology and Hepatology, Reina Sofía University Hospital, Córdoba, Spain.
  • Lyons M; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Siakavellas SI; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Constantine-Cooke N; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK; Centre for Genomics and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, Scotland,
  • Jenkinson P; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • O'Hare C; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Noble C; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Arnott ID; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
  • Jones GR; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK; Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Scotland, UK.
  • Lees CW; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK; Centre for Genomics and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.
Dig Liver Dis ; 55(8): 1034-1041, 2023 08.
Article em En | MEDLINE | ID: mdl-36283944
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Fármacos Dermatológicos / Ustekinumab Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Fármacos Dermatológicos / Ustekinumab Idioma: En Ano de publicação: 2023 Tipo de documento: Article